The KÆRTOR Foundation

The Kærtor Foundation is an initiative of global reach, a pioneer in open innovation and public-private co-development in drug discovery. It provides continuity to the results of the University of Santiago de Compostela (USC) Innopharma project and is led by Professors Mabel Loza, a specialist in Pharmacology, and Ángel Carracedo, a specialist in Genomic Medicine.

A PIONEER RESEARCH INITIATIVE FOR EARLY DRUG DISCOVERY IN COLLABORATION WITH INDUSTRY

Our mission is to promote the reciprocal transfer of knowledge in a circular, translational drug discovery process, generating synergies that increase the value and accelerate the procedure.

datos-kaertor-13
1

Call for Expressions of Interest open

datos-kaertor-10
2

million euros for early drug discovery

kaertor_eoi_received
157

EoIs received in total

datos-kaertor-08
5

strategic agreements in reverse transfer

THE MAIN AIMS OF THE
KÆRTOR FOUNDATION

WHAT IS REVERSE TRANSFER?

  • The application of transformational science in disease mechanisms to medical and industrial demands
  • Finding the best ideas anywhere in the world and applying them in Galicia with the pharmaceutical companies